Refine by
Allergy Reaction Articles & Analysis
61 news found
Aeroallergens, which are airborne substances such as mold or pollen that can trigger an allergic reaction in some people following inhalation or dermal contact, are often found in dust. In some asthmatics, aeroallergens could trigger an asthma attack, or potentially worsen other respiratory diseases. When dust is airborne, it can remain in the air for long periods of time and settle throughout ...
Their newest production discusses latex allergy, which is a reaction to certain proteins found in latex rubber. ...
Both furry pets and those with feathers can cause an allergic reaction in some people. Pet dander is a significant source of pet allergens and is composed of proteins from flecks of skin shed by pets. ...
Both furry pets and those with feathers can cause an allergic reaction in some people. Pet dander is a significant source of pet allergens and is composed of proteins from flecks of skin shed by pets. ...
While most species of Fusarium are harmless, others can cause costly plant damage or spoil cereal crops through the production of mycotoxins, including fumonisins and trichothecenes. Exposure to Fusarium can even cause potential health issues for humans and animals. In homes and buildings that have suffered water damage or elevated humidity levels, Fusarium is sometimes found in surface and air ...
CD Formulation, a leading provider of contract pharmaceutical formulation development services, recently announced the launch of its dissolving microneedle preparation services. This breakthrough in drug delivery technology promises to revolutionize the way medications are administered, enhancing efficiency and patient comfort. Microneedles are tiny, painless needles that penetrate the skin's ...
As we move towards the New Year, we’ll be anxiously awaiting the warming days of springtime. Well, most of us will anyway. Fortunately for many of us, and unfortunately for many others, it means flowers will be in bloom after spring rains and some of us will be suffering with seasonal allergic rhinitis, more commonly referred to as hay fever. It’s all about the coughing, the red ...
There are many known asthma triggers, but one of the more common ones is exposure to elevated levels of mold. This information is important for asthmatics, especially those living in Puerto Rico which has some of the highest asthma rates in the United States. Across the entire country, asthma caused 5.8 million physician office visits and 1.6 million emergency department visits as recently as ...
VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced it has entered into a refinanced and upsized debt facility of up to $100 million with its existing lender, K2 HealthVentures (K2HV), a healthcare-focused specialty finance company. Under the terms of the agreement, $50 million is ...
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) (Valneva) and VBI Vaccines Inc. (Nasdaq: VBIV) (VBI) today announced a partnership in select European markets for the marketing and distribution of PreHevbri® [Hepatitis B vaccine (recombinant, adsorbed)], the only 3-antigen hepatitis B vaccine approved in Europe. Under the terms of the agreement, specialty vaccine company Valneva will promote ...
Small procedures on the body, like a skin biopsy, are great candidates for local anesthesia. An injection or topical cream may be used. If you’ve ever had an injection by a dentist, you’ve had a local anesthetic. Fast-acting, virtually pain-free and convenient, local anesthetics enable much of medicine to occur. Patients can remain awake and leave following their procedure. After ...
VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that John Dillman has been appointed as the Company’s Chief Commercial Officer. Mr. Dillman will be responsible for leading VBI’s commercial strategy, sales, and sales operations, including the commercialization of ...
VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that new data from a follow-up analysis of a subset of participants from the pivotal Phase 3 study (PROTECT) of the Company’s 3-antigen prophylactic hepatitis B (HBV) vaccine, were presented in an oral presentation at The ...
VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that an abstract highlighting long-term durability of immune response data following vaccination with VBI’s 3-antigen hepatitis B (HBV) vaccine has been accepted for oral presentation at The International Liver ...
It is very common among childhood allergies. Toddlers often have more severe reactions, displaying all symptoms of an allergic reaction including vomiting. ...
This Christmas season, when families gather together and consume tasty holiday foods, it is essential to be aware of allergic reactions, which usually increase during this period. Food allergies are estimated to affect 1% to 10% of adults and children in developed countries[1]. Notably, young children, especially toddlers, are at a higher risk of the potential ...
Unlike COVID-19, seasonal allergies aren't caused by a virus. Seasonal allergies are immune system responses triggered by exposure to allergens, such as seasonal tree or grass pollens. To complicate the situation, allergy sufferers are experiencing longer allergy seasons, earlier onset, and there is just more pollen in the air. ...
DUPIXENT can cause serious side effects, including: Allergic reactions. DUPIXENT can cause allergic reactions that can sometimes be severe. ...
DUPIXENT can cause serious side effects, including: Allergic reactions. DUPIXENT can cause allergic reactions that can sometimes be severe. ...
NEW YORK, April 06, 2022 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, Inc., a New York-based, clinical stage biotechnology company developing a patient-friendly treatment platform for peanut and other food allergies, today announced that its ongoing Phase 1 OMEGA Clinical Study of INT301 in adult patients with peanut allergy has been amended to allow ...